Saving lives – with and beyond dialysis
Doubling up on a second chance
A robot at the operating table
Midwife, a dream job
My 50 years of dialysis
An almost irreplaceable organ
Living life to the fullest with dialysis
Growing up with parenteral nutrition
The History of Dialysis
Serving patients in Swaziland
"I want to help others, so they won’t give up"
From a local pharmacy to a global corporation
Q3/21 Results
Fresenius improves FY/21 Group guidance for the second time after good Q3 results
-
Fresenius Medical Care with stronger than projected COVID-19 related headwind
-
Fresenius Kabi improves EBIT outlook; North America returning to growth; Emerging Markets business with continued healthy financial performance
-
Helios Germany with ongoing upward trend for elective treatments; activity levels at Helios Spain above pre-pandemic levels
-
Fresenius Vamed with good performance in the service business; order book in the project business remains at all-time high
-
Cost and efficiency program on track; savings targets confirmed for FY/23
-
Fresenius raises FY/21 Group sales outlook; earnings now expected to be around the top-end of guidance
